10-Q
XBRL
10-Q
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Filed
- November 5, 2024
- Period of Report
- September 30, 2024
- Accession Number
- 0000875320-24-000223
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →